The wish list from business ahead of Rishi Sunak’s speech

As UK faces spiralling raw material costs, staff shortages, and rising energy prices, here is what CEOs want from chancellor

Novozymes A/S (NVZMY)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

70.94+1.11 (+1.59%)

At close: 3:45PM EDT

Loading interactive chart…

Zacks
ICL or NVZMY: Which Is the Better Value Stock Right Now?
ICL vs. NVZMY: Which Stock Is the Better Value Option?
Globe Newswire
Novozymes is unlocking growth with the ambition of doubling company revenue by 2030
With the launch of “Unlocking Growth – Powered by Biotech” Novozymes presents its 2025-strategy. It sets out an organic sales growth target of 5+% CAGR for the 5-year period until 2025, coupled with the ambition to double the company’s revenue by 2030. COPENHAGEN, DENMARK – 27 September 2021 – “Unlocking Growth – Powered by Biotech” is Novozymes’ strategy towards 2025 based on the solid foundation and successful execution of “Better Business with Biology”. As part of ‘Unlocking Growth’ Novozymes
Globe Newswire
Novozymes announces its 2025 strategy: Unlocking growth – powered by biotech
Please read the full announcement in PDF Attachment 2021_46_Novozymes_announces_ 2025_strategy